{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:08:57Z","timestamp":1767830937985,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,25]]},"DOI":"10.7759\/cureus.24465","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T12:02:48Z","timestamp":1650888168000},"source":"Crossref","is-referenced-by-count":2,"title":["Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients"],"prefix":"10.7759","author":[{"given":"Mintcho E","family":"Mintchev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun G","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Ting J","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K","family":"Aden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L","family":"Bezzant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfred P","family":"dela Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian R","family":"Bersabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: burdens upon an aging, changing nation","volume":"27","author":"Smith BD","year":"2009","unstructured":"Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009, 27:2758-65. 10.1200\/JCO.2008.20.8983","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria A","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG, et al.. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011, 29:3457-65. 10.1200\/JCO.2011.34.7625","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/11591990-000000000-00000","article-title":"Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study","volume":"28","author":"Crome P","year":"2011","unstructured":"Crome P, Lally F, Cherubini A, et al.. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging. 2011, 28:667-77. 10.2165\/11591990-000000000-00000","journal-title":"Drugs Aging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration","volume":"22","author":"Talarico L","year":"2004","unstructured":"Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004, 22:4626-31. 10.1200\/JCO.2004.02.175","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins LF","year":"1999","unstructured":"Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999, 341:2061-7. 10.1056\/NEJM199912303412706","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0186","article-title":"The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer","volume":"17","author":"Hamaker ME","year":"2012","unstructured":"Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist. 2012, 17:1439-49. 10.1634\/theoncologist.2012-0186","journal-title":"Oncologist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2018.08.010","article-title":"Predicting chemotherapy toxicity in older adults: comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement","volume":"10","author":"Moth EB","year":"2019","unstructured":"Moth EB, Kiely BE, Stefanic N, et al.. Predicting chemotherapy toxicity in older adults: comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement. J Geriatr Oncol. 2019, 10:202-9. 10.1016\/j.jgo.2018.08.010","journal-title":"J Geriatr Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2020.100042","article-title":"A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS study","volume":"6","author":"Gomes F","year":"2021","unstructured":"Gomes F, Lorigan P, Woolley S, Foden P, Burns K, Yorke J, Blackhall F. A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS study. ESMO Open. 2021, 6:100042. 10.1016\/j.esmoop.2020.100042","journal-title":"ESMO Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93867-use-of-a-chemotherapy-toxicity-prediction-tool-to-decrease-risks-for-hospitalization-in-older-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:17Z","timestamp":1707507437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93867-use-of-a-chemotherapy-toxicity-prediction-tool-to-decrease-risks-for-hospitalization-in-older-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.24465","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,25]]}}}